Catheter-Directed Intra-Arterial Abciximab Administration for Acute Thrombotic Occlusions during Neurointerventional...

Area of Science:

• Neurointerventional Radiology
• Vascular Surgery
• Pharmacology

Background:

• Abciximab, a platelet aggregation inhibitor, is primarily used for acute coronary syndromes and cardiac interventions.
• Emerging applications include neurointerventional procedures for preventing and treating acute vessel occlusions.
• Current administration is typically via systemic intravenous infusion.

Purpose of the Study:

• To evaluate the efficacy of intra-arterial abciximab administration in neurointerventional procedures.
• To assess the role of abciximab in managing acute vessel occlusions during neurointerventions.

Main Methods:

• Retrospective analysis of five cases involving acute vessel occlusion during neurointerventional procedures.
• Intra-arterial administration of an abciximab bolus directly at or near the site of occlusion.
• Visual assessment of thrombus dissolution and neurological outcomes.

Main Results:

• Rapid and complete visual thrombus dissolution was observed in four out of five cases.
• Partial thrombus dissolution occurred in one case.
• Neurological outcomes included two patients with no deficits, one with no further deterioration, one with mild residual deficit, and one with a severe deficit.

Conclusions:

• Intra-arterial abciximab administration is a promising approach for managing acute vessel occlusions in neurointerventional settings.
• This method demonstrated rapid and effective thrombus dissolution, potentially improving clinical outcomes.
• Further research is warranted to establish optimal protocols and long-term efficacy.